x

Coronavirus

Hungary Issued Final Approval to Chinese COVID-19 Vaccine

February 19, 2021

BUDAPEST— Hungarian health authorities issued final approval to a COVID-19 vaccine produced in China, clearing the way for the first inoculations with a Chinese vaccine in the European Union.

Hungary’s chief medical officer, Cecilia Muller, said during a press briefing that examinations of the Sinopharm vaccine by the country’s National Public Health Center had found it to be in line with documentation provided by its developer. Hungary received 550,000 doses of the vaccine on Tuesday, enough to treat 275,000 people with the two-round jab.

Prime Minister Viktor Orban said that he expected a rapid acceleration of vaccinations in coming days, and that health authorities planned to inoculate 650,000 people within a week to 10 days. Hungary has vaccinated 391,821 people to date.

RELATED

BEIJING (AP) — The hunt for the origins of COVID-19 has gone dark in China, the victim of political infighting after a series of stalled and thwarted attempts to find the source of the virus that killed millions and paralyzed the world for months.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

Over 100 Pilot Whales Beached on Western Australian Coast Have Been Rescued, Officials Say

MELBOURNE, Australia (AP) — More than 100 long-finned pilot whales that beached on the western Australian coast Thursday have returned to sea, while 29 died on the shore, officials said.

On Monday, April 22, 2024, history was being written in a Manhattan courtroom.

PARIS - With heavy security set for the 2024 Paris Olympic Games during a time of terrorism, France has asked to use a Greek air defense system as well although talks are said to have been going on for months.

WASHINGTON (AP) — A tiny Philip Morris product called Zyn has been making big headlines, sparking debate about whether new nicotine-based alternatives intended for adults may be catching on with underage teens and adolescents.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.